...
首页> 外文期刊>Transplant infectious disease: an official journal of the Transplantation Society >Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease.
【24h】

Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease.

机译:JC和BK多瘤病毒在肾脏移植受者和慢性肾脏病患者中的感染率。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study investigated the prevalence of infection by JC and BK polyomaviruses (JCV and BKV) in patients with chronic renal disease (CRD), kidney transplant recipients, and a control group of asymptomatic subjects. We tested a total of 295 urine samples. After DNA extraction, polymerase chain reaction assay was used to amplify a fragment of 173 bp of the polyomavirus T antigen, followed by analysis using the BamHI restriction endonuclease. Infection by polyomavirus was detected in 17.6% (52/295 subjects) of the subjects. Whereas 30.5% (18/59) of transplant recipients were infected, the frequency was only 22.4% (30/134) in the control subjects, and 3.9% (4/102) in the CRD group (all JCV). The vast majority of infections (88.9%; 16/18) in transplant recipients were of the BKV type, whereas this type was absent in CRD patients, and made up only 10.0% (3/30) of infections in the control group. The risk of BKV infection was 72 times greater in renal transplant patients than in asymptomatic subjects. The low frequency of infection found in CRD patients may have been related to elevated levels of urea excreted in the urine, together with reduced urine volume and cell content. These factors may combine to reduce viral load or inhibit amplification. The results of the study indicate a need for the routine screening for polyomavirus in pre- and post-transplant patients, as well as organ donors, considering that BKV infection has been associated with graft rejection in kidney transplants.
机译:本研究调查了JC和BK多瘤病毒(JCV和BKV)在慢性肾脏病(CRD)患者,肾移植受者和无症状对照组中的感染率。我们总共测试了295个尿液样本。 DNA提取后,使用聚合酶链反应分析法扩增多瘤病毒T抗原的173 bp片段,然后使用BamHI限制性核酸内切酶进行分析。在17.6%(52/295名受试者)的受试者中检测到多瘤病毒感染。尽管有30.5%(18/59)的移植受体被感染,但在对照组中该频率仅为22.4%(30/134),而在CRD组(均为JCV)中这一频率仅为3.9%(4/102)。移植受者中的绝大多数感染(88.9%; 16/18)是BKV型,而在CRD患者中则没有这种类型的感染,在对照组中仅占感染的10.0%(3/30)。肾移植患者中BKV感染的风险是无症状患者的72倍。在CRD患者中发现的低感染频率可能与尿液中尿素排出水平升高以及尿液量和细胞含量减少有关。这些因素可以结合起来减少病毒载量或抑制扩增。研究结果表明,考虑到BKV感染与肾脏移植物中的移植排斥有关,需要对移植前和移植后患者以及器官供体进行例行的多瘤病毒常规筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号